PharmaBoardroom

NEW Spain Pharma Report Out Now!

Having largely recovered from the impact of the global financial crisis and with several impressive fundamentals in place, Spain once again stands as…

Regulatory Reform: Singapore

Upcoming regulatory reforms in Singaporean pharma. Prepared in association with Drew & Napier LLC, this is an extract from The Pharma Legal…

Patents and Trademarks: Singapore

What you need to know about patents and trademarks in Singaporean pharma. Prepared in association with Drew & Napier LLC, this is an extract…

Product Liability: Singapore

Key legal info on product liability in Singaporean pharma. Prepared in association with Drew & Napier LLC, this is an extract from The Pharma…

Traditional Medicines & OTC Products: Singapore

Want to know more about traditional medicines and OTC products in Singapore? Read on! Prepared in association with Drew & Napier LLC, this is an…

Marketing, Manufacturing, Packaging & Labeling, Advertising:…

Everything you need to know about the marketing, manufacturing, packaging, labeling and advertising of pharmaceuticals in Singapore. Prepared in…

Preclinical and Clinical Trial Requirements: Singapore

The key facts about conducting preclinical and clinical trials in Singapore. Prepared in association with Drew & Napier LLC, this is an extract…

Regulatory, Pricing and Reimbursement: Singapore

All about regulation, pricing and reimbursement in Singaporean pharma. Prepared in association with Drew & Napier LLC, this is an extract from The…

Javier Urzay – Deputy Director, Farmaindustria, Spain

Javier Urzay, deputy director of Farmaindustria, gives an overview of the growth of the pharmaceutical sector in Spain and the challenges to find a…

Jin-San Yoo – President & CEO, PharmAbcine, South…

Dr Jin San-Yoo, president and CEO of PharmAbcine, lifts the lid on the company’s combination therapy with MSD’s blockbuster oncology treatment…

David Lescuyer – Managing Director, Skyepharma, France

David Lescuyer, managing director of Skyepharma, a specialized CDMO, reflects on the past three years of the company as it transitioned from a drug…

NEW Turkey Pharma Report Out Now!

Turkey – home to an 80 million-strong population, a substantial pharmaceuticals market and a universal healthcare system that is the envy of its…

Tagged with ARM